Analytics

Articles

Shimadzu’s Nexera MP UHPLC Front End system for LC/MS is perfect for LC/MS analysis conducted in pharmacokinetics and synthesis stages in drug detection processes. read more

The Nexera MP UHPLC for LC/MS analysis in drug  detection processes

Shimadzu’s new LCMS-8060 is designed to push the limits of LC/MS/MS quantitation for applications requiring the highest sensitivity and robustness while delivering a meaningful solution for routine LC/MS/MS analyses.

Changes Everything – LCMS-8060 triple quadrupole mass spectrometer expands UFMS family

Shimadzu’s newLCMS-8060 is designed to push the limits of LC/MS/MS quantitation for applications requiring the highest sensitivity and robustness while delivering a meaningful solution for routine LC/MS/MS analyses.

Changes Everything–LCMS-8060 triple quadrupole mass spectrometer expands UFMS family

Shimadzu’s Nexera MP UHPLC Front End system for LC/MS is perfect for LC/MS analysis conducted in pharmacokinetics and synthesis stages in drug detection processes.

The Nexera MP UHPLC for LC/MS analysis in drug detection processes

Geoff Carr is the Director of Analytical Development at Patheon located in Mississauga, Ontario. His email is geoff.carr@patheon.com.

The author describes how liquid chromatography-mass spectrometry works and explains some of its advantages and disadvantages, particularly compared to high-performance liquid chromatography.

Using Tandem LC-MS for Cleaning Validation

Cadnel Detchou, Analytical Bio-Chemistry Laboratories

Rowel Tobias, Analytical Bio-Chemistry Laboratories

John Anders, Analytical Bio-Chemistry Laboratories

The authors describe two applications of a modified mass-spectrometry (MS) method, multiple reaction monitoring (MRM-MS), in biopharmaceutical analysis.

Multiple Reaction Monitoring–Mass Spectrometry for Biopharmaceutical Analysis

This article presents the successful analysis of metabolic products from microsomal incubations of a common pharmaceutical compound.

Bio/Pharmaceutical Analysis, LC-MS